A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris

NCT03341910 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: DFD-03 Lotion, 0.1%
DRUG: Tazorac Cream, 0.1%
DRUG: DFD-03 Vehicle Lotion 0%
DRUG: Tazorac Vehicle Cream 0%

Sponsor

Dr. Reddy's Laboratories Limited